Antibiotics require a prescription because they carry risks that make them unsafe for self-treatment. Unlike a pain reliever or antacid, choosing the right antibiotic depends on identifying which type of bacteria is causing an infection, something that typically requires lab tests or clinical evaluation. The FDA will only approve a drug for over-the-counter sale when consumers can use it safely and effectively without professional supervision, and antibiotics fail that test on multiple levels.
What the FDA Requires for OTC Status
For any drug to move from prescription to over-the-counter, the manufacturer must prove that consumers can understand how to use it correctly on their own. The FDA’s standard is straightforward: a drug stays prescription-only when its “toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use” make professional oversight necessary. Antibiotics check every one of those boxes.
Picking the right antibiotic isn’t like choosing between ibuprofen and acetaminophen. A doctor needs to determine whether your infection is bacterial at all (most sore throats and colds are viral), identify which organism is likely responsible, and select the drug that targets it. Clinicians use tools like blood markers that help distinguish viral from bacterial infections, urine tests to confirm urinary tract infections before prescribing, and throat cultures to identify strep. Without that diagnostic step, you’d essentially be guessing.
Self-Medication Drives Antibiotic Resistance
The single biggest reason antibiotics stay behind the pharmacy counter is resistance. When bacteria are exposed to antibiotics unnecessarily or at the wrong dose, the survivors adapt. Over time, infections that once responded to cheap, common drugs become treatable only with expensive, last-resort options, or not at all. Resistant infections already cost the U.S. healthcare system more than $4.6 billion annually, and that figure covers only six of the eighteen most concerning resistant organisms tracked by the CDC.
The pattern is well documented in countries where antibiotics are sold without a prescription. Across parts of Africa, Asia, South America, and even some European countries like Greece, Italy, and Spain, pharmacies sell antibiotics directly to consumers. The consequences are measurable. In Bolivia, researchers found that 40% of children carried gut bacteria resistant to the most commonly purchased antibiotics. A follow-up study eight years later showed multidrug resistance had climbed to 90% of bacterial samples. In Vietnam and Thailand, communities with high rates of non-prescription antibiotic use consistently show elevated resistance levels.
The flip side is equally telling. After Chile began enforcing prescription requirements, antibiotic consumption dropped and resistance in common gut bacteria appeared to decline. Pakistan saw a similar pattern: as antibiotic use fell, resistance in a dangerous strain of Salmonella dropped alongside it.
What People Self-Treat With (and Why It Backfires)
In countries where antibiotics are available without a prescription, people overwhelmingly use them for conditions that don’t need them. The most common targets are the common cold, flu symptoms, diarrhea, and sore throats, all of which are usually caused by viruses that antibiotics can’t touch. Amoxicillin accounts for about 41% of self-medicated antibiotic use, followed by metronidazole at 17% and a combination of ampicillin and cloxacillin at 16%.
Alexander Fleming himself warned about this in his Nobel Prize lecture. He described a hypothetical person who “buys some penicillin and gives himself, not enough to kill the streptococci but enough to educate them to resist penicillin.” That scenario plays out constantly when people dose themselves without guidance. They may take too little, pick the wrong drug entirely, or use a broad-spectrum antibiotic when a narrow one would work better.
Antibiotics Can Cause Serious Harm
Antibiotics aren’t gentle drugs. They don’t selectively target the bacteria making you sick. They sweep through your entire body, killing beneficial microbes along the way. Your gut microbiome, the trillions of bacteria that support digestion, immune function, and metabolism, takes a significant hit from even a single course. Research in animal models shows that while the total number of gut bacteria bounces back within days, the diversity of species may never fully recover. One study found that certain important bacterial groups permanently lost 36% to 70% of their diversity after a single antibiotic course.
That disruption has real consequences. One of the most dangerous is infection with C. difficile, a bacterium that thrives when antibiotics wipe out the competition. In 2023, the CDC recorded about 117 cases per 100,000 people at its surveillance sites, and 63% of those patients had used antibiotics in the prior 12 weeks. C. diff causes severe diarrhea, can lead to life-threatening colon inflammation, and is notoriously difficult to treat once established.
Allergic reactions are another concern that requires professional screening. About 10% of Americans report a penicillin allergy, though testing reveals that fewer than 1% are truly allergic. A doctor can assess your history and, when needed, recommend alternatives. Without that step, someone with a genuine allergy could face a reaction ranging from rash to anaphylaxis.
Why the Prescription Step Matters
The prescription requirement isn’t just a bureaucratic hurdle. It’s a checkpoint that accomplishes several things at once. It confirms whether you actually have a bacterial infection. It matches you with the antibiotic most likely to work against your specific pathogen. It sets the right dose and duration for your body weight, kidney function, and other medications. And it creates a record that helps track resistance patterns in your community.
Dosing is more complex than most people realize. Taking too little antibiotic exposes bacteria to the drug without killing them, which is precisely how resistance develops. But the old advice to “always finish the full course” is more nuanced than it sounds. Recent evidence suggests that prolonged exposure to antibiotics can also drive resistance, meaning the ideal duration depends on clinical judgment, not a one-size-fits-all rule printed on a box.
That kind of nuanced decision-making is exactly what makes antibiotics a poor fit for the OTC shelf. A label can tell you how many milligrams to take. It can’t evaluate whether you need the drug at all, or adjust your treatment when your symptoms change three days in. As long as picking the right antibiotic requires a diagnosis, and as long as getting it wrong fuels a global resistance crisis, these drugs will stay where they are: behind a prescription.